OPTINOSE

optinose-logo

OptiNose develops nasal drug delivery technologies and novel combination drug/device therapies. The drug delivery technologies are based upon a unique and patent-protected principal "Bi-Directional Delivery" which allows drugs to be more efficiently delivered to the nasal cavity. By applying its drug delivery technology, most of the dose is deposited beyond the nasal valve in the upper posterior two-thirds of the nasal cavity, unlike traditional devices. The OptiNose delivery devices have high d... ose reproducibility and avoid drug deposition to the lungs. In summary, technology fulfills the ideal requirements for nasal drug delivery. Clinical trials have shown that devices can provide a faster onset of action, greater effect with a lower dose, and reduced side effects. The company has offices in Norway and the UK.

#SimilarOrganizations #People #Financial #Event #Website #More

OPTINOSE

Social Links:

Industry:
Biotechnology Medical Device Pharmaceutical

Founded:
2000-01-01

Address:
Oslo, Oslo, Norway

Country:
Norway

Website Url:
http://www.optinose.com

Total Employee:
101+

Status:
Active

Contact:
267-364-3500

Email Addresses:
[email protected]

Total Funding:
401.43 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon WordPress Google Universal Analytics Wordpress Plugins


Similar Organizations

apellis-pharmaceuticals-logo

Apellis Pharmaceuticals

Apellis Pharmaceuticals focusesย on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.

aprecia-pharmaceuticals-logo

Aprecia Pharmaceuticals

Aprecia Pharmaceuticals develops precision drug delivery systems and products.

cequr-logo

CeQur

CeQur develops and commercializes insulin delivery systems, giving people with type 2 diabetes freedom from multiple daily injections.

fgen-logo

FGen

FGen develops proprietary technologies and products in different biotechnological areas.

myomo-logo

Myomo

Myomo develops devices with myoelectric prosthetic technology to restore the mobility of individuals with muscle weakness.

oxsonics-therapeutics-logo

OxSonics Therapeutics

OxSonicsยฎ Therapeuticsโ€™ proprietary drug delivery platform technology, SonoTranยฎ


Current Advisors List

klaas-de-boer_image

Klaas de Boer Board of Directors @ OptiNose
Board_member
2010-01-01

Current Employees Featured

per-djupesland_image

Per Djupesland
Per Djupesland Founder & CSO @ OptiNose
Founder & CSO

peter-k-miller_image

Peter K. Miller
Peter K. Miller CEO @ OptiNose
CEO

ramy-a-mahmoud_image

Ramy A. Mahmoud
Ramy A. Mahmoud COO @ OptiNose
COO

helena-djupesland_image

Helena Djupesland
Helena Djupesland Vice President, Business Development @ OptiNose
Vice President, Business Development
2010-06-01

mike-marino_image

Mike Marino
Mike Marino Chief Legal Officer @ OptiNose
Chief Legal Officer

not_available_image

Anthony Krick
Anthony Krick VP and Chief Accounting Officer @ OptiNose
VP and Chief Accounting Officer
2022-01-01

victor-clavelli_image

Victor Clavelli
Victor Clavelli Chief Commercial Officer @ OptiNose
Chief Commercial Officer
2020-02-01

michele-janis_image

Michele Janis
Michele Janis Acting Chief Financial Officer @ OptiNose
Acting Chief Financial Officer
2022-06-01

Founder


helena-djupesland_image

Helena Djupesland

per-djupesland_image

Per Djupesland

Stock Details


Company's stock symbol is NASDAQ:OPTN

Investors List

pharmakon-advisors_image

Pharmakon Advisors

Pharmakon Advisors investment in Post-IPO Debt - OptiNose

athyrium-capital-management_image

Athyrium Capital Management LP

Athyrium Capital Management LP investment in Post-IPO Debt - OptiNose

avista-capital-partners_image

Avista Capital Partners

Avista Capital Partners investment in Series D - OptiNose

fidelity-management-and-research-company_image

Fidelity Management and Research Company

Fidelity Management and Research Company investment in Series D - OptiNose

entrepreneurs-fund_image

Entrepreneurs Fund

Entrepreneurs Fund investment in Series D - OptiNose

avista-capital-partners_image

Avista Capital Partners

Avista Capital Partners investment in Series C - OptiNose

the-entrepreneurs-fund-iii_image

The Entrepreneurs' Fund

The Entrepreneurs' Fund investment in Series C - OptiNose

wfd-ventures_image

WFD Ventures

WFD Ventures investment in Series C - OptiNose

avista-capital-partners_image

Avista Capital Partners

Avista Capital Partners investment in Series C - OptiNose

entrepreneurs-fund_image

Entrepreneurs Fund

Entrepreneurs Fund investment in Series C - OptiNose

Key Employee Changes

Date New article
2022-06-03 Optinose Announces Departure of Chief Financial Officer

Official Site Inspections

http://www.optinose.com Semrush global rank: 2.7 M Semrush visits lastest month: 6.13 K

  • Host name: 20.119.8.33
  • IP address: 20.119.8.33
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "OptiNose" on Search Engine